Category

share

TRIPS Agreement and Indian Pharmaceutical Industry

TRIPS Agreement and Indian Pharmaceutical Industry

 

Marketed By :  LAP LAMBERT Academic Publishing   Sold By :  Kamal Books International  
Delivery in :  10-12 Business Days

 
₹ 5,886

Availability: Out of stock

 

Delivery :

5% Cashback on all Orders paid using MobiKwik Wallet T&C

Free Krispy Kreme Voucher on all Orders paid using UltraCash Wallet T&C
Product Out of Stock Subscription

(Notify me when this product is back in stock)

  • Product Description
 

TRIPS throws a new challenge to the competitiveness and profitability of Indian pharma industry as it ended decades of protection by terminating “reverse-engineering.” The effect of TRIPS on FDI, R&D, technology transfer, etc. is also not clear. More importantly, the new IP regime may have far-reaching consequences on accessibility & affordability of drugs to the poor in developing and LDCs. The book is divided into three essays. The first essay investigates the emerging firm strategies of the Indian pharma industry to overcome the challenge posed by the new IP regime, and concludes that the industry is adopting a mix of competitive, collaborative, and R&D strategies. The second essay examines the effect of TRIPS on FDI, and concludes that merely enhancing IP protection may not lead to increase in FDI. The third essay explores the effectiveness of CL in controlling drug prices, and consequently its affordability & accessibility to the poor. It concludes that the issues relating to CL are part of a much wider structural problem in development policy, and the solution to inaccessibility of drugs requires mix policy interventions, including the smooth functioning of CL system.

Product Specifications
SKU :COC71566
Country of ManufactureIndia
Product BrandLAP LAMBERT Academic Publishing
Product Packaging InfoBox
In The Box1 Piece
Product First Available On ClickOnCare.com2015-10-08
0 Review(s)